Skip to main content

Table 8 Strategies in the use of CHDF (25 facilities responded)

From: Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy

Strategies

Number (%)

Nafamostat

3 (12.0)

AN69ST membrane

4 (16.0)

PMMA membrane

1 (4.0)

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us